IP Library Granted Patent US 10,301,346
Granted Patent B2
US 10,301,346 · App. 15/343,267 · Granted May 28, 2019

Nucleotide analogues

Inventors: Mong Sano Marma (Natick, MA); Jerzy Olejnik (Brookline, MA); Ilia Korboukh (Needham, MA)
Assignee: Qiagen Sciences, LLC
C07H19/10C07C323/12C07C323/60C07D207/46C07F7/1804C07H19/14C09B1/00C09B5/2436C09B11/24C09B23/083C09B23/166C12Q1/6811C12Q1/6869C12Q1/6876C07C2603/18Y02P20/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,301,346
App. No.
15/343,267
Granted
May 28, 2019
Kind
B2
Abstract

The present invention provides methods, compositions, mixtures and kits utilizing deoxynucleoside triphosphates comprising a 3′-O position capped by a group comprising methylenedisulfide as a cleavable protecting group and a detectable label reversibly connected to the nucleobase of said deoxynucleoside. Such compounds provide new possibilities for future sequencing technologies, including but not limited to Sequencing by Synthesis.

Claims (20)

1. A deoxynucleoside triphosphate having the structure:

wherein D is a cleavable protecting group selected from the group consisting of an disulfide alkyl, disulfide substituted alkyl groups, disulfide allyl, and disulfide substituted allyl groups; B is a nucleobase; A is an attachment group selected from the group consisting of exocyclic amine, propargyl amine, and propargyl hydroxyl;

C is a cleavable site core selected from the group consisting of:

wherein R 1 and R 2 are independently selected alkyl groups; L 1 and L 2 are connecting groups; and Label is a detectable label selected from the group consisting of fluorophore dyes, energy transfer dyes, mass-tags, biotin, and haptenes.

2. The deoxynucleoside triphosphate according to claim 1 , wherein said nucleobase is non-natural.

3. The deoxynucleoside triphosphate according to claim 2 , wherein the non-natural nucleobase is selected from the group consisting of 7-deaza guanine, 7-deaza adenine, 2-amino,7-deaza adenine, and 2-amino adenine.

4. The deoxynucleoside triphosphate according to claim 1 , wherein said cleavable protecting group is of the formula —CH 2 —SS—R, wherein R is selected from the group consisting of alkyl and substituted alkyl groups.

5. The deoxynucleoside triphosphate according to claim 1 , wherein said detectable label is a fluorescent label.

6. A labeled deoxynucleoside triphosphate according to the following structure:

wherein D is a cleavable protecting group selected from the group consisting of an disulfide alkyl, disulfide substituted alkyl groups, disulfide allyl, and disulfide substituted allyl groups; B is a nucleobase, A is an attachment group selected from the group consisting of propargyl, exocyclic amine, propargyl amine, and propargyl hydroxyl; C is a cleavable site core selected from the group consisting of:

wherein R 1 and R 2 are independently selected alkyl groups;

and L 1 and L 2 are connecting groups, wherein L 1 is selected from the group consisting of —CONH(CH 2 ) x —, —CO—O(CH 2 ) x —, —CONH—(OCH 2 CH 2 O) x —, —CO—O(CH 2 CH 2 O) x —, and —CO(CH 2 ) x —, wherein x is 0-10; and wherein L 2 is selected from the group consisting of —CO—, —CONH—, —NHCONH—, —O—, —S—, —C═N, and —N═N—, alkyl, aryl, branched alkyl, branched aryl and combinations thereof and, wherein the label is a detectable label selected from the group consisting of fluorophore dyes, energy transfer dyes, mass-tags, biotin, and haptenes.

7. The labeled deoxynucleoside triphosphate according to claim 6 , wherein L 2 is not —S—.

8. A deoxynucleoside triphosphate having the structure:

wherein D is a cleavable protecting group selected from the group consisting of an disulfide alkyl, disulfide substituted alkyl groups, disulfide allyl, and disulfide substituted allyl groups; B is a nucleobase;

Linker comprises a cleavable oxymethylenedisulfide-containing site core, wherein said cleavable site core is selected from the group consisting of:

wherein R 1 and R 2 are independently selected alkyl groups; and Label is a detectable label selected from the group consisting of fluorophore dyes, energy transfer dyes, mass-tags, biotin, and haptenes.

9. The deoxynucleoside triphosphate according to claim 1 , wherein L 1 is selected from the group consisting of—CONH(CH 2 ) x —, —CO—O(CH 2 ) x —, —CONH—(OCH 2 CH 2 O) x —, —CO—O(CH 2 CH 2 O) x —, and —CO(CH 2 ) x —, wherein x is 0-10.

10. The deoxynucleoside triphosphate according to claim 1 , wherein L 2 is selected from the group consisting of

—NH—, —(CH 2 ) x —NH—, —C(Me) 2 (CH 2 ) x NH—, —CH(Me)(CH 2 ) x NH—, —C(Me) 2 (CH 2 ) x CO—, —CH(Me)(CH 2 ) x CO—, —(CH 2 ) x OCONH(CH 2 ) y O(CH 2 ) z NH—, —(CH 2 ) x CONH(CH 2 CH 2 O) y (CH 2 ) z NH—, —(CH 2 ) x OCONH(CH 2 CH 2 O) y (CH 2 ) z NH—, and —CONH(CH 2 ) x —, —CO(CH 2 ) x —, wherein x, y, and z are each independently selected from is 0-10.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Jul 31, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES LLC
Reel/Frame 046519/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2018
From: MARMA, MONG SANO; OLEJNIK, JERZY; KORBOUKH, ILIA
To: QIAGEN WALTHAM, INC.
Reel/Frame 045836/0882 →
CHANGE OF NAME Recorded May 17, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 047132/0861 →
Continuity (3)
Provisional Application 62251884 · Nov 6, 2015
Provisional Application 62327555 · Apr 26, 2016
Related Publication 20170130051A1 · May 11, 2017
Cited By (2)
US 12,188,086 US 12,337,009